science1 publisher
Ariadne Bio aims a non-hallucinogenic 5-HT2A agonist at Parkinson's apathy
Palomar Labs' first spinout is built on a molecule whose parent compound was tested in the 1970s and documented not to be hallucinogenic. Apathy affects about 40% of people with Parkinson's, and no drug is approved for it.
Publishers:genengnews.com
Reality
- Evidence40
- Adoption8
- Hype gap+35
- Incentives82
- Confidence42